| abstract |
Composition and method of treating malaria in a human having an infestation of Plasmodium protozoans are described. The method comprises administering a therapeutically-effective amount of a compound of formula (I) or (IV), i.e. sufficient quantity to reduce the population of Plasmodium. The substituents are detailed in the specification, desferrithiocin and derivatives thereof are comprised within the compounds of formula (I). |